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Abstract: Antibiotic exposure early in life and other practices impacting the vertical transmission and
ordered assembly of a diverse and balanced gut microbiota are associated with a higher risk of immuno-
logical and metabolic disorders such as asthma and allergy, autoimmunity, obesity, and susceptibility to
opportunistic infections. In this study, we used a model of perinatal exposure to the broad-spectrum
antibiotic ampicillin to examine how the acquisition of a dysbiotic microbiota affects neonatal immune
system development. We found that the resultant dysbiosis imprints in a manner that is irreversible
after weaning, leading to specific and selective alteration of the colonic CD4+ T-cell compartment. In
contrast, colonic granulocyte and myeloid lineages and other mucosal T-cell compartments are unaf-
fected. Among colonic CD4+ T cells, we observed the most pronounced effects on neuropilin-negative,
ROR฀t- and Foxp3-positive regulatory T cells, which are largely absent in antibiotic-exposed mice even
as they reach adulthood. Immunomagnetically isolated dendritic cells from antibiotic-exposed mice fail
to support the generation of Foxp3+ regulatory T cells (Tregs) from naive T cells ex vivo The perina-
tally acquired dysbiotic microbiota predisposes to dysregulated effector T-cell responses to Citrobacter
rodentium or ovalbumin challenge. The transfer of the antibiotic-impacted, but not healthy, fecal micro-
biota into germfree recipients recapitulates the selective loss of colonic neuropilin-negative, ROR฀t- and
Foxp3-positive Tregs. The combined data indicate that the early-life acquisition of a dysbiotic microbiota
has detrimental effects on the diversity and microbial community composition of offspring that persist
into adulthood and predisposes to inappropriate T-cell responses that are linked to compromised immune
tolerance.IMPORTANCE The assembly of microbial communities that populate all mucosal surfaces of
the human body begins right after birth. This process is prone to disruption as newborns and young
infants are increasingly exposed to antibiotics, both deliberately for therapeutic purposes, and as a conse-
quence of transmaternal exposure. We show here using a model of ampicillin administration to lactating
dams during their newborn offspring’s early life that such exposures have consequences that persist into
adulthood. Offspring acquire their mother’s antibiotic-impacted microbiota, which compromises their
ability to generate a colonic pool of CD4+ T cells, particularly of colonic regulatory T cells. This Treg
deficiency cannot be corrected by cohousing with normal mice later and is recapitulated by reconstitu-
tion of germfree mice with microbiota harvested from antibiotic-exposed donors. As a consequence of
their dysbiosis, and possibly of their Treg deficiency, antibiotic-impacted offspring generate dysregulated
Th1 responses to bacterial challenge infection and develop more severe symptoms of ovalbumin-induced
anaphylaxis.
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ABSTRACT Antibiotic exposure early in life and other practices impacting the verti-
cal transmission and ordered assembly of a diverse and balanced gut microbiota are
associated with a higher risk of immunological and metabolic disorders such as
asthma and allergy, autoimmunity, obesity, and susceptibility to opportunistic infec-
tions. In this study, we used a model of perinatal exposure to the broad-spectrum an-
tibiotic ampicillin to examine how the acquisition of a dysbiotic microbiota affects
neonatal immune system development. We found that the resultant dysbiosis imprints
in a manner that is irreversible after weaning, leading to specific and selective altera-
tion of the colonic CD41 T-cell compartment. In contrast, colonic granulocyte and my-
eloid lineages and other mucosal T-cell compartments are unaffected. Among colonic
CD41 T cells, we observed the most pronounced effects on neuropilin-negative,
RORgt- and Foxp3-positive regulatory T cells, which are largely absent in antibiotic-
exposed mice even as they reach adulthood. Immunomagnetically isolated dendritic
cells from antibiotic-exposed mice fail to support the generation of Foxp31 regulatory
T cells (Tregs) from naive T cells ex vivo. The perinatally acquired dysbiotic microbiota
predisposes to dysregulated effector T-cell responses to Citrobacter rodentium or oval-
bumin challenge. The transfer of the antibiotic-impacted, but not healthy, fecal micro-
biota into germfree recipients recapitulates the selective loss of colonic neuropilin-neg-
ative, RORgt- and Foxp3-positive Tregs. The combined data indicate that the early-life
acquisition of a dysbiotic microbiota has detrimental effects on the diversity and micro-
bial community composition of offspring that persist into adulthood and predisposes to
inappropriate T-cell responses that are linked to compromised immune tolerance.
IMPORTANCE The assembly of microbial communities that populate all mucosal surfa-
ces of the human body begins right after birth. This process is prone to disruption
as newborns and young infants are increasingly exposed to antibiotics, both deliber-
ately for therapeutic purposes, and as a consequence of transmaternal exposure. We
show here using a model of ampicillin administration to lactating dams during their
newborn offspring’s early life that such exposures have consequences that persist
into adulthood. Offspring acquire their mother’s antibiotic-impacted microbiota, which
compromises their ability to generate a colonic pool of CD41 T cells, particularly of co-
lonic regulatory T cells. This Treg deficiency cannot be corrected by cohousing with
normal mice later and is recapitulated by reconstitution of germfree mice with micro-
biota harvested from antibiotic-exposed donors. As a consequence of their dysbiosis,
and possibly of their Treg deficiency, antibiotic-impacted offspring generate dysregulated
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Th1 responses to bacterial challenge infection and develop more severe symptoms of
ovalbumin-induced anaphylaxis.
KEYWORDS CD4 T cells, Treg deficiency, broad-spectrum antibiotics, colonic regulatory
T cells, dysregulated Th1 responses, dysregulated immune response, metabolic
disorders, microbiota, transmaternal exposure
The lifelong process of the colonization of environmentally exposed surfaces ofmammals—such as the skin, mouth, gut and vagina—begins at birth, with the
infant acquiring its primordial microbiota from the mother (1–5). Of all the microbially
colonized niches of the body, the lower gastrointestinal tract harbors by far the most
abundant community of resident microbes, and by adulthood, it is colonized by thou-
sands of species and on the order of 100 trillion microbial cells (6–9). These microbes
provide numerous benefits to their host, including the processing of otherwise indi-
gestible compounds, production of nutrients and vitamins, defense against pathogens,
and education of the mucosal immune system (3–5, 10–13). Diverse molecular interac-
tions between resident microbes and their mucosal niche direct the development of
immune cell populations and immune responses, and these, in turn, help shape the
composition of the microbiota (11, 14–16).
Early life is the critical period for the development and assembly of the mature
microbiome in humans and mice (16–20). The dysbiosis of resident microbes has been
linked to both immunological and metabolic disorders, including allergy, autoimmun-
ity, inflammatory bowel disease, and obesity, as well as to opportunistic infections (3,
21–24, 84, 85). Consequently, the disruption of microbial communities, or interference
with their assembly and maturation in the first weeks and months of life, predisposes
to a higher risk of developing asthma and other allergies (25–27), obesity and type 2
diabetes (28–30), type I diabetes (31, 32), and other manifestations of autoimmunity
later in life (33) and reduces neonatal immune defenses against viral (34) and bacterial
(35–37) pathogens in humans and/or experimental animals. Cesarean section delivery,
formula instead of breastfeeding, and early-life exposure to antibiotics all have been
linked to higher rates of such metabolic, chronic inflammatory, and immunological dis-
orders (3, 4, 16, 20, 38, 39, 84, 85). Infants and young children may be exposed to anti-
biotics either directly for the purpose of treatment of respiratory, cutaneous, or gastro-
intestinal infection, subtherapeutically through their mothers perinatally or during
breastfeeding, or through environmental exposures. In the United States, more than
40% of pregnant women receive antibiotics in labor, either for group B streptococcus
(GBS) prophylaxis or to prevent postpartum infections after cesarean delivery (40, 41),
and 70% of infants receive antibiotics in the first year of life (27, 39); the most com-
monly used antibiotics in both settings are b-lactams.
In this study, we sought to investigate whether perinatal exposure of lactating
dams and their pups to the commonly prescribed broad-spectrum b-lactam antibiotic
ampicillin would affect the developing neonatal immune system of the offspring, in
particular at mucosal sites known to host a resident microbiota. We found that this an-
tibiotic exposure has long-term effects on the diversity and community structure of
the gastrointestinal microbiota and has strong and persistent effects on the T-cell com-
partment of the intestinal immune system. The observed changes could be recapitu-
lated by fecal transplantation into germfree mice and resulted in dysregulated Th1 and
Th2 immune responses to infectious and allergen challenge later in life.
RESULTS
Perinatal antibiotic exposure has lasting consequences for the composition
and diversity of the gut microbiota of offspring. Exposure to antibiotics early in life,
either directly through administration to newborn pups or via indirect, transmaternal
exposure of suckling pups to antibiotics in their mothers’ milk, is known to be detri-
mental in adults in models of obesity, type I diabetes, allergic asthma, and bacterial
infection (12, 28, 30, 31, 33, 42). To examine whether the exposure of lactating dams
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and pups to antibiotics affects the microbiota composition of their offspring, we
administered the broad-spectrum b-lactam ampicillin to dams via the drinking water
at a calculated therapeutic dose of 100mg/kg of body weight/day when their offspring
were between 5 and 10 days old. Both the offspring and their mothers were sacrificed
when the offspring reached 24, 33, or 45 days of age, and DNA extracted from ileal,
cecal, colonic, and fecal samples was used for microbial community analysis based on
high-throughput 16S rRNA V4 region sequencing. As determined by calculating both
unweighted and weighted UniFrac distances, microbial communities at all three sam-
pling sites and in the feces differed significantly between offspring of control and
ampicillin-exposed mice, and these differences persisted over time; as expected, the
offspring clustered with their respective mothers without exception (Fig. 1A; see also
Fig. S1A in the supplemental material) (P, 0.001, Adonis test). Species richness and
evenness were significantly lower in offspring of ampicillin-treated mice at all three pri-
mary sampling sites and at all three time points (Fig. 1B; Fig. S1B) (P, 0.05, Wilcoxon
rank sum test), although not in the feces. Consistent with their overall reduced diver-
sity, offspring of ampicillin-exposed mice showed reduced amplicon sequence variants
(ASVs), with very few ASVs (e.g., Akkermansia) being more abundant (Fig. 1C).
Unsupervised hierarchical clustering of the DESeq2-derived variance stabilized transformed
(vst) count data of differentially abundant ASVs between microbiota samples (false-discov-
ery rate [FDR], 0.01) segregated the offspring of control and ampicillin-treated dams
onto two distinct branches of the taxonomic heat map, with few exceptions (Fig. 1D;
Fig. S1C), with the offspring clustering with their respective mothers (Fig. 1D; Fig. S1C).
Differentially abundant taxa at the genus level that were selectively lost in virtually all off-
spring of ampicillin-exposed dams included Muribaculum intestinale, Culturomica massilien-
sis, Prevotella shahii, and two Bacteroides species (Bacteroides rodentium and B. caecimuris)
(Fig. 1E). Clostridial species, including Clostridium aldenense, C. indolis, and C. amygdalinum,
bloomed in a subset of offspring of antibiotic-exposed dams (Fig. 1D; Fig. S1C). The com-
bined data suggest that as few as 5 days of such antibiotic exposure during lactation pro-
foundly alters the microbial community structure and composition of the offspring, persist-
ing into young adulthood.
Early-life antibiotic exposure dysregulates colonic lamina propria CD4+ T-cell
populations. In parallel to the analysis of the gut microbiota, we systematically investi-
gated whether, and how, such ampicillin exposure affects the developing murine
immune system of the offspring. We isolated leukocytes at the same three time points
as used for 16S rRNA analyses and sampled multiple lymphoid and nonlymphoid tissues,
including stomach, colon, mesenteric lymph nodes (MLNs), and lung. Multidimensional
flow cytometric analyses were performed on single-cell suspensions to determine the
abundance and frequencies of specific myeloid populations, granulocytes and T-lympho-
cytes. The dominant myeloid and two major granulocyte populations of the lung, lymph-
oid tissues, and the gastrointestinal (GI) tract lamina propria (LP) were largely unchanged
by the ampicillin exposure (as shown representatively for macrophages, monocytes, and
the three major populations of dendritic cells (DCs) as well as neutrophils and eosino-
phils of the colonic LP in Fig. S2A). In contrast, in the ampicillin-exposed mice, CD41 T
cells were reduced in both number and frequency in the colonic LP relative to controls
(Fig. 2A and B), as were CD81 T cells (Fig. S2A). The selective reduction of T cells was spe-
cific for the colon and not observed in the gastric LP, lung, or MLNs (Fig. S2B to D).
Among CD41 T cells, both Foxp31 regulatory T cells and Foxp32 T cells were reduced in
absolute numbers, reflecting the generally reduced pool of CD41 T cells (Fig. 2C to E).
Two subsets of regulatory T cells (Tregs) co-occur in the colonic LP and MLNs; one subset
is selected in the thymus and expresses neuropilin-1 (Nrp-1), whereas the other arises in
the periphery, is Nrp-1 negative, and is considered “peripherally induced” (“pTregs”) (43).
Such Nrp-12 Tregs represent an extremely abundant population in colons colonized by
a healthy and diverse microbiota, where they comprise the majority of all Tregs (Fig. 2F
to H) and approximately one-fifth of all T cells (Fig. 2B and H). Only Nrp-12 Tregs were
selectively absent in the colonic LP and MLNs of offspring of ampicillin-treated mice,
with reductions in their absolute numbers by 60 to 80%, whereas Nrp-11 Tregs were
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FIG 1 Perinatal maternal antibiotic exposure has long-lasting consequences for the gastrointestinal microbiota of offspring. Dams and their offspring were
exposed to ampicillin via the drinking water from day 5 to 10 of the pups’ lives. 16S rRNA sequencing was performed on mouse intestinal tract and fecal
(Continued on next page)
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present at normal levels (Fig. 2F to H; Fig. S2D). The colonic Nrp-12 Tregs that were under-
represented in the antibiotic-exposed mice express the transcription factor RORgt (Fig. 2I
and J), a common property of GI tract resident Tregs (44). The selective Nrp-12 RORgt1
Treg deficiency in the antibiotic-exposed mice persisted into early adulthood (Fig. 2F to J).
Cohousing of the offspring of antibiotic-exposed mice with age-matched normal
control mice for 4 weeks starting at the time of weaning failed to reverse the conse-
quences of antibiotic exposure; rather, cohoused normal mice adopted the Treg defi-
ciency of their dysbiotic cage mates (Fig. S2E). This finding is consistent with our previ-
ous observation that the antibiotic-perturbed dysbiosis invades, and ultimately
dominates over, a healthy, diverse gastrointestinal microbiota (29). Direct (as opposed
to transmaternal) exposure of newborn pups on days 5 to 10 of age to ampicillin
administered at a therapeutic dose (100mg/kg/day) had no effects on colonic Treg
populations as assessed at 45 days of age (Fig. S2E).
To address whether the colonic Treg reduction in offspring of antibiotic-exposed
mice is due to defects in their local expansion, we stained for Ki67 as a marker of prolif-
eration. The vast majority of colonic Nrp-12 Tregs were Ki67 positive, and the fre-
quency of Ki67-positive Nrp-12 Tregs did not differ between treatments (Fig. S2F). The
combined data collected across time points and in several lymphoid and nonlymphoid
tissues indicate that (i) CD41 T-cell residence in the colon, but less so at other mucosal
sites, requires an unperturbed microbiota and (ii) populations of Nrp-12 RORgt1 colo-
nic regulatory T cells are selectively and disproportionately dependent on a healthy
and diverse community of intestinal microbes.
Dendritic cells from antibiotic-pretreated donors are incapable of Treg
generation ex vivo. We next asked whether the selective Treg deficiency observed in
the colons and MLNs of antibiotic-exposed mice is due to numerical defects or, alterna-
tively, to functional defects of dendritic cells and their ability to promote Foxp3 expres-
sion and Treg differentiation in cocultured naive T cells. We first examined the frequen-
cies of the dominant colonic and MLN DC populations but found no major numerical
differences (Fig. S3A and B). We then immunomagnetically isolated CD11c1 dendritic
cells from the MLNs of the antibiotic-exposed or control mice and cocultured them
with naive splenic T cells, which were assessed by flow cytometry for Foxp3 expression
3 days later. Whereas dendritic cells from donors with an unperturbed microbiota
induced strong Foxp3 expression in the cocultured T cells, this was markedly reduced
for dendritic cells from the dysbiotic donors (Fig. 3). Since DCs migrating to the MLNs
from the colonic LP provide the initial signals during the multistep process of Treg
induction and intestinal tolerance development, which begins with DC-dependent
Treg priming in the MLNs and is followed by Treg homing to the gut and their local
expansion in the colonic LP (45), our data indicate that antibiotic-induced dysbiosis
leads to Treg deficiency by compromising the tolerogenic activities of dendritic cells.
The reconstitution of germfree mice with microbiota harvested from antibiotic-
exposed mice recapitulates the effects on colonic CD4+ T cellularity and Treg
populations. To determine whether the dysbiosis per se, rather than other physiologi-
cal consequences of the ampicillin exposure, causes the selective loss of CD41 T-cell
FIG 1 Legend (Continued)
samples. (A) Unweighted UniFrac beta diversity, rarefied at 5,000 reads, was plotted along two principal-component axes, plots separated by body site;
each ellipse represents the 95% confidence interval for that treatment group. Samples are color-coded by treatment (control, red; ampicillin, blue) and
generation; symbols indicate the age of the offspring mice at the specified sample collection. Adonis testing was used to determine whether there were
significant differences (P, 0.01) between microbial communities based on treatment at each body site. (B) Alpha diversity, based on Shannon species
evenness, was calculated for the offspring mice in each treatment group by body site, and statistical significance was determined by Wilcoxon rank sum
test. *, P, 0.05; **, P, 0.01; ***, P, 0.001; NS., not significant. (C) Sequence variant counts of offspring fecal and colonic microbiota were combined within
treatment groups, and relative taxonomic abundance at the genus level was determined and plotted for the 50 most abundant taxa. (D) The DESeq2
pipeline was used to generate a heatmap of the 93 significantly differentially abundant taxa (P, 0.01) across a total of 229 samples from 67 control or
ampicillin-exposed mice (48 samples from cecum, 52 from colon, 55 from ileum, and 74 from feces). Clustering is unsupervised, and bars along the top of
the plot are used to indicate treatment, body sampling site, and the mouse generation from which the samples were collected. Phyla are shown along the
left side of the heat map. Taxonomy at the order level is color-coded at the right side. (E) Differentially abundant taxa in the colonic microbiota between
control and ampicillin-exposed and control mice were determined using DESeq2 at the genus level. Only taxa significantly enriched in control (right side of
plot) or significantly enriched in the ampicillin-exposed mice (left side of plot) at a P value of ,0.01 are shown.
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FIG 2 Perinatal maternal antibiotic exposure alters offspring colonic lamina propria CD41 T-cell population frequencies and absolute numbers. Dams and
their offspring were exposed to ampicillin via the drinking water from day 5 to 10 of the pups’ lives, and colonic lamina propria leukocyte populations of
offspring were isolated at the age of 24, 33, or 45 days and analyzed by flow cytometry. (A and B) Absolute counts per organ, and frequencies among live
cells, of CD41 T cells in the colonic lamina propria. Representative fluorescence-activated cell sorting (FACS) plots are shown in panel A, and summary plots
are shown in panel B. (C to E) Absolute counts, and frequencies among all CD41 T cells, of Foxp31 Tregs (D) and Foxp32 effector T cells (E). Representative
FACS plots are shown in panel C. (F to H) Absolute counts per organ, and frequencies among all Foxp31 Tregs, of neuropilin-1-positive (Nrp-11) Tregs (G)
and Nrp-12 Tregs (H). Representative FACS plots are shown in panel F. (I and J) Absolute counts per organ, and frequencies among all Foxp31 Tregs, of
RORgt1 Nrp-12 Tregs. Representative FACS plots are shown in panel I. Two independent studies were pooled for the day 33 and 45 time points, and one
study is shown for the day 24 time point. Horizontal lines indicate medians throughout; statistical analyses used the Mann-Whitney test. *, P, 0.05; **,
P, 0.01; ***, P, 0.005; ****, P, 0.001. Only statistically significant differences are indicated with asterisks.
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populations in the colonic LP, we asked whether the perturbed microbiota could trans-
fer the phenotypes. To determine this, we harvested fecal pellets from 3-week-old anti-
biotic-exposed or control pups and transferred the microbial communities into germ-
free recipient mice. After 4 weeks of engraftment, the recipients were analyzed with
respect to their colonic microbiome relative to the microbiome of the donor mice and
subjected to multidimensional flow cytometric analysis of colonic LP T-cell popula-
tions. Based on both unweighted and weighted UniFrac distance analyses, the altered
microbial community structure of the donor mice was clearly recapitulated in the
germfree recipients as assessed by their segregation based on treatment (Fig. 4A;
Fig. S4A) (P, 0.001, Adonis test). The reduced diversity of the antibiotic-exposed
donors was also recapitulated in the conventionalized recipient mice, with the transfer
contributing to a further reduction of both the richness and the evenness of the micro-
biota in both groups of recipient mice, independent of donor source (Fig. 4B). Analysis
of the germfree recipients also indicated that the antibiotic-induced microbiota altera-
tions persisted over time and across experiments and hygienic conditions (Fig. S4B).
Flow cytometric analysis of colonic LP leukocyte populations revealed that the
germfree mice conventionalized with an ampicillin-perturbed microbiota had a dra-
matic reduction of CD41 T-cell absolute numbers and frequencies among all colonic
live cells (Fig. 4C), which was reflected also in the Treg and effector T-cell counts
(Fig. 4D and E) and the counts of Treg subpopulations (Fig. 4F and G). In the colonic LP
of the now conventionalized recipients, most Tregs were of extrathymic rather than
thymic origin, as assessed by both their neuropilin-1 and RORgt expression (Fig. 4H),
recapitulating the representation of the two Treg populations of mice raised under
specific-pathogen-free (SPF) conditions (Fig. 2F to J). While the frequencies of Tregs
among CD41 T cells and of Treg subpopulations were not significantly different in the
two groups of recipients, we observed that Nrp-1-positive Tregs appeared less affected
by the ampicillin exposure of the donors than Nrp-1-negative RORgt-expressing Tregs
(Fig. 4D to H). Analysis of the MLNs of the recipients of antibiotic-impacted microbiota
revealed only modest reductions in CD41 T-cell and Treg cellularity that were not stat-
istically significant (Fig. S4C to G). Collectively, the results indicate that a healthy,
diverse and unperturbed microbiota is key for the normal development of the resident
colonic LP CD41 T-cell population, with strong reductions observed in both regulatory
and conventional CD41 T cells.
Dysbiotic mice generate excessive effector T-cell responses to bacterial
pathogen or allergen challenge. To address whether the reduction in colonic regula-
tory T cells that results from early-life dysbiosis affects immune responses to bacterial
or allergen challenge, we first infected ampicillin-exposed or control pups with
Citrobacter rodentium, a mouse-restricted Gram-negative pathogen that induces a
FIG 3 Dendritic cells isolated from the MLNs of dysbiotic offspring of antibiotic-exposed dams are less capable
of inducing Foxp3 expression in cocultured naive T cells than DCs from control offspring. Immunomagnetically
isolated MLN CD11c1 DCs from 45-day-old offspring of antibiotic-exposed dams and age-matched control
offspring were cultured at 1:5 ratios with naive splenic T cells (20,000 DCs and 100,000 T cells). Cocultures were
stained for CD4, and Foxp3 and Treg populations were quantified by flow cytometry. (A) Representative FACS
plots of the indicated conditions. (B) Summary plot of all cocultures; data are pooled from two independent
experiments. Each symbol represents one coculture; two cultures were assessed per mouse. Horizontal lines
indicate medians; statistical analyses used the Mann-Whitney test. *, P, 0.05.
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mixed Th1/Th17 response and is a model of human colonic infections (46, 47). C. roden-
tium colonizes the cecum and colon and can spread to the MLNs; its ability to colonize
the murine GI tract and cause disease is influenced by the status of commensal popula-
tions (12) and presence of individual species such as segmented filamentous bacteria
(“Candidatus Savagella” species) (48). Mice were infected with C. rodentium at 7 weeks
of age and assessed with respect to bacterial colonization and colonic LP T-cell
responses 2 weeks later. The extents of C. rodentium colonization of the cecum, colon,
and MLNs were similar in the antibiotic-exposed and control mice (Fig. 5A). The infec-
tion caused a robust influx of CD41 T cells into the infected colonic LP, which also was
unaffected by the early-life dysbiosis (Fig. 5B). However, ex vivo restimulation of T cells
with phorbol myristate acetate (PMA) and ionomycin revealed that Th1, but not Th17,
responses were higher in the dysbiotic mice (Fig. 5C and D; Fig. S5A and B). Next, we
turned to a model of ovalbumin (OVA)-induced food allergy, for which mice were first
sensitized intraperitoneally with alum-adjuvanted ovalbumin and then challenged
orally with ovalbumin on four consecutive days. Mice were scored daily for the devel-
opment of anaphylactic symptoms and assessed with respect to their splenic Th2
FIG 4 Fecal transplantation of antibiotic-perturbed microbiota into germfree mice recapitulates the colonic CD41 T-cell and Treg phenotypes of the
donors. Fecal microbiota from 3-week-old offspring of control or ampicillin-exposed dams (two donors each) was collected and transferred by oral gavage
to 6- to 8-week-old germfree recipients. Microbial community structure and CD41 T cell populations were analyzed 28 days posttransfer. (A) Unweighted
UniFrac distance rarefied at 5,000 reads with the 95% confidence intervals around each recipient group; the Adonis test was used to determine statistical
significance. (B) Taxonomic abundance in the now-conventionalized recipient mice compared to the fecal inocula transferred from antibiotic-perturbed or
control donors. (C to H) Colonic lamina propria T-cell populations in the now-conventionalized, formerly GF mice. (C) Absolute counts per organ, and
frequencies among live cells, of CD41 T cells in the colonic lamina propria. (D and E) Absolute counts per organ, and frequencies among all CD41 T cells,
of Foxp31 Tregs (D) and Foxp32 effector T cells (E). (F and G) Absolute counts per organ, and frequencies among all Foxp31 Tregs, of Nrp-11 Tregs (F) and
Nrp-12 Tregs (G). (H) Absolute counts per organ, and frequencies among all Foxp31 Tregs, of RORgt1 Nrp-12 Tregs. Data in panels A and B are from two
independent studies; data in panels C to H are from one study. GFCtrl and GFAmp, conventionalized, previously germfree recipients of control and ampicillin-
impacted fecal inocula; InoculumCtrl and InoculumAmp, fecal inocula used for conventionalization. Horizontal lines indicate medians throughout; statistical
analyses used the Mann-Whitney test. **, P, 0.01.
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FIG 5 Antibiotic exposure of dams results in dysregulated Th1 responses of dysbiotic offspring to Citrobacter rodentium infection and in differential food
allergy severity. (A to D) Offspring of control and ampicillin-exposed dams were intragastrically infected with Citrobacter rodentium at 7 weeks of age and
(Continued on next page)
Antibiotic-Impacted Microbiota Compromises T Cells ®
















































cytokine production at the study endpoint. The antibiotic-exposed pups showed
trends toward higher anaphylaxis scores (repeated scratching around the nose and
mouth, puffy eyes and nose, and reduced activity [Fig. 5E]) and expressed somewhat
higher levels of splenic interleukin 5 (IL-5) and IL-13 as assessed by enzyme-linked immu-
nosorbent assay (ELISA) and reverse transcription-quantitative PCR (qRT-PCR) after ex vivo
restimulation with ovalbumin (Fig. S5C and D). Ovalbumin sensitization and challenge
resulted in an increase in the frequencies of Tregs, especially of Nrp-12 Tregs, in the MLNs;
however, the increased frequency of Tregs was reduced in antibiotic-exposed mice (Fig. 5F
and G). A small fraction of Nrp-12 Tregs in MLNs were positive for Ki67, and this fraction
was reduced in antibiotic-exposed mice (Fig. 5H). The combined results indicate that early-
life dysbiosis of the small intestine and colon affects T-cell responses to infectious chal-
lenge in the colon and causes somewhat enhanced systemic responses to an orally admin-
istered antigen in a food allergy model.
DISCUSSION
We show here that the exposure of lactating dams and pups to a broad-spectrum
b-lactam antibiotic causes persistent dysbiosis and a reduction of colonic CD41 T cells
and, in particular, of colonic Nrp-12 RORgt1 Tregs. These effects were specific to the
colon and not observed in the lungs, upper GI tract, or spleen. Myeloid and granulo-
cyte populations did not differ in the offspring, suggesting that T cells, but not other
leukocyte lineages, are selectively dependent on a healthy, diverse gut microbiota.
Only extrathymically induced Nrp-12 RORgt1 Tregs, and not thymus-derived Nrp-11
Tregs (which we, like others investigators, for lack of other markers distinguish largely
based on the surface marker Nrp-1 [43]), depend on an unperturbed gut microbiota.
Previous work, mostly conducted using germfree mice, has documented important
roles of intestinal microbes in colonic Treg induction (49). In addition to other deficits
in the development of the gut-associated lymphoid tissues (GALT), including reduced
number and size of Peyer’s patches and MLNs, germfree mice have reduced frequen-
cies and absolute numbers of colonic, but not small intestinal, Tregs, which can be
reversed by the introduction of an altered Schaedler flora (50) or a mixture of
Clostridium species (49). While the ability to induce colonic Tregs was initially proposed
to be a trait of Gram-positive bacteria (49), it is now clear that both Gram-positive and
Gram-negative GI tract resident bacterial species can effectively induce Tregs with highly
suppressive activity in both the colon and other gastrointestinal tissues. Examples
include Helicobacter pylori colonizing the stomach (51), Helicobacter hepaticus colonizing
the cecum (52, 53), and a group of 12 human commensal species (from both
Bacteroidetes and Firmicutes, including lactobacilli) which in a monocolonization model
of germfree mice all were able to induce Nrp-12 RORgt1 Tregs (44). The order
Bacteroidales, especially the genus Bacteroides, was particularly rich in species able to
induce colonic Tregs in a large-scale screen designed to identify bacterial species among
human fecal microbiota that in monocolonization models of germfree mice exhibit that
trait (54). Our observation that the genus Bacteroides is underrepresented in ampicillin-
impacted communities is consistent with the prior studies.
Colonic Nrp-12 RORgt1 Treg differentiation is a multistep process that is initiated in
the MLNs by a tissue-derived migratory CD1031 DC population that drives Foxp3 and
FIG 5 Legend (Continued)
sacrificed 2 weeks later. (A) C. rodentium colonization of the cecum, colon, and MLNs as determined by plating and colony counting. (B) Absolute counts
per organ, and frequencies among all live cells, of CD41 T cells in the colonic lamina propria as determined by flow cytometry. (C and D) Frequencies of
IFN-g1 CD41 T cells among all CD41 T cells, as assessed by ex vivo restimulation with PMA/ionomycin. Representative FACS plots are shown in panel C.
Data in panels A to D are pooled from two independent experiments. (E to H) Offspring of control and ampicillin-exposed dams were intraperitoneally
immunized twice with alum-adjuvanted ovalbumin at 5 and 7weeks of age and challenged on four consecutive days with orally administered ovalbumin 4
weeks after the first sensitization (s/c). Control mice were sensitized with ovalbumin but mock challenged with PBS only. Additional controls were mock
sensitized and mock challenged with PBS only. (E) Cumulative anaphylaxis score over 4 days. (F) Frequencies of Foxp31 Tregs among all CD41 T cells in
MLNs. (G) Frequencies of Nrp-12 cells among all Foxp31 Tregs in MLNs. (H) Frequencies of Ki671 cells among all Nrp-12 Foxp31 Tregs in MLNs. Data in
panels E to H are pooled from two experiments. Horizontal lines indicate medians throughout; statistical analyses were done using the Mann-Whitney test.
*, P, 0.05; **, P, 0.01; ***, P, 0.005. Only statistically significant differences are indicated with asterisks.
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gut homing receptor expression in naive T cells (55–57). MLN DCs cross talk with stro-
mal cells in the MLNs, and both compartments are key cellular sources of tolerogenic
molecules, including retinoic acid, transforming growth factor b (TGF-b), and BMP2,
which are all known to drive Treg differentiation (56–59). While migratory CD1031 DCs,
presenting luminal antigens they have encountered in the gastrointestinal tract,
appear to contribute more effectively to overall Treg generation in the MLNs, MLN resi-
dent DCs also have Treg-inducing capacity, which appears to be imprinted by stromal
cells in a microbiota-dependent manner in the neonatal period and mediated by the
TGF-b superfamily member BMP2 (59). Tregs generated de novo in the MLNs subse-
quently migrate to and expand within the intestinal lamina propria (45), and these
processes are supported by microbiota and their metabolic products (60, 61). Our data
are consistent with the notion that a diverse and healthy microbiota is required at the
earliest steps in Treg priming that happen in the MLNs, based on three observations: (i)
DCs isolated from antibiotic-impacted MLNs are less capable of Treg induction in vitro
than DCs from control mice; (ii) ovalbumin-induced Treg -and especially Nrp-12
RORgt1 Treg- populations are reduced in the MLNs of antibiotic-impacted, ovalbumin-
challenged mice; and (iii) the fraction of proliferating Tregs is reduced in the MLNs, but
not the colonic LP, of antibiotic-impacted mice. The last observation suggests that
once de novo-induced Tregs have successfully trafficked to the colonic LP, they have
become largely independent of microbial or other environmental cues; our results
therefore are consistent with the concept that neonatal tolerogenic imprinting affects
extrathymic Treg generation at the priming stage in MLNs.
Both Nrp-12 (p)Tregs and thymus-derived Tregs, and subsets of both populations,
have alternatively been implicated in generating and maintaining immune tolerance
of intestinal commensals and in suppressing excessive effector T-cell responses to
pathogens (62–65). However, the current consensus is that extrathymically induced
Tregs are the main drivers of tolerance to food and commensal antigens and essential
for intestinal homeostasis (44, 45, 66–68). Colonic Treg induction has been attributed
to the ability of commensals to produce the short-chain fatty acids (SCFAs) butyrate,
acetate, and propionate (68), which—when administered in purified form—are suffi-
cient to drive colonic Treg differentiation and alleviate immunopathology in several
Treg-controlled disease models (69). In our model of antibiotic exposure leading to
dysbiosis, we observed the most robust Treg shifts in neuropilin-12 Tregs that express
RORgt. Several studies have documented the suppressive activity of RORgt1 Foxp31
Tregs, and the critical role of RORgt expression in Foxp31 Tregs, in models of type I
and type II immunity. The specific ablation of RORgt in Foxp31 Tregs was sufficient to
exacerbate 2,4,6-Trinitrobenzenesulfonic acid (TNBS)-induced colitis driven by pathogenic
Th1 and Th17 cells (44) but also the Th2-driven pathology of oxazolone-induced colitis
(70). Th2-driven helminth control was improved in mice lacking RORgt specifically in
Foxp31 Tregs (70). Furthermore, the success of experimental therapy of Th2-driven food
allergy with two different bacterial consortia, consisting of either Clostridiales or
Bacteroidales species, required RORgt expression in Foxp31 Tregs (71). These cells selec-
tively suppressed specific Th17 responses in a Helicobacter hepaticus-driven model of colo-
nic RORgt1 Foxp31 Treg generation and function (52). We observe robust effects of the
early-life dysbiosis on Th1 (but not Th17) responses to Citrobacter rodentium challenge and
modest effects on Th2 responses to orally administered ovalbumin. The latter result paral-
lels earlier studies that have reported more severe allergic airway inflammation and atopic
dermatitis in mice subjected to early life therapeutic antibiotic exposure (72–74). The com-
bined data from our model support several previous studies that have implicated colonic
RORgt1 Tregs in the rather general (nonselective) suppression of various types of T-helper
(Th1, Th2, and Th17) responses (49, 68). This feature sets these cells apart from T-bet-
expressing Tregs, which exclusively arise in Th1-polarized settings and are functionally spe-
cialized to suppress Th1 but not other T-helper cells (75, 76).
Our metagenomics analyses have revealed that the dams’ dysbiotic microbiome
invariably clusters with their offspring’s microbiomes. Two alternative mechanisms can
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in principle result in the persistent shifts in the composition of the gut microbiota and
the co-occurring changes in the Treg populations that we observed in the offspring.
On the one hand, antibiotics in an exposed dam’s milk (77) may directly select colonic
microbes as the microbiota population structure is gradually assembling in the suck-
ling mice. Alternatively, the pups acquire their mother’s antibiotic-impacted dysbiotic
microbiota during the critical neonatal window, with little chance to adjust its compo-
sition once that dysbiotic community has stabilized. The fact that cohousing with nor-
mal control mice fails to reverse the Treg phenotype indicates the importance of these
early-life effects, which are consistent with our prior studies (28).
Our model of transmaternal antibiotic exposure recapitulates many aspects of peri-
natal antibiotic exposure in human children, including intrapartum antibiotic prophy-
laxis (IAP), i.e., the common practice of administering high doses of intravenous antibi-
otics (penicillin or ampicillin) to prevent early-onset neonatal group B streptococcal
(GBS) disease. IAP has been identified as a major cause of disrupted microbiota trans-
mission from mother to neonate in a UK study examining 596 full-term babies (36),
with reduced intergenerational transmission of Bacteroides species being particularly
prevalent as a consequence of IAP (36) and/or C-section delivery (20). In the former
study, children born by Cesarean section or exposed to IAP were more likely to be colon-
ized by nosocomial pathogens (including Enterococcus, Enterobacter, and Klebsiella spe-
cies) than controls (36); IAP also has been independently linked to early-onset neonatal
sepsis (35). Experimental evidence suggests that both transmaternal and direct antibiotic
exposure of neonatal mice compromises CD81 T-cell responses to Escherichia coli K-12
or Klebsiella pneumoniae-induced neonatal sepsis (37) and to viral pathogens such as
vaccinia virus (34) or lymphocytic choriomeningitis virus (LCMV) and influenza virus (21).
Our results provide experimental evidence for the notion that the development not
only of antiviral or antibacterial immunity, as shown in the above-mentioned studies,
but also of immune regulation is compromised by an antibiotic-impacted dysbiotic
microbiota in early life. Perinatal dysbiosis persists into adulthood and is not readily
reversed by exposure to an unperturbed microbiota after weaning. We show that
early-life dysbiosis is linked to dendritic cell dysfunction and results in dysregulated
effector T-cell responses to an intestinal pathogen and in more severe food allergy.
MATERIALS ANDMETHODS
Animal experimentation. C57BL/6 mice were purchased from Janvier and bred and maintained
under specific-pathogen-free conditions in certified animal facilities at the University of Zurich. For anti-
biotic exposure, ampicillin was dissolved in distilled deionized water at a concentration of 0.333mg/ml,
and mice were exposed to ampicillin through their mothers’ milk as described previously (77, 78); alter-
natively, neonatal mice were treated by oral gavage on five consecutive days with ampicillin for a daily
dose of 100mg/kg of body weight. For use in fecal microbiota transplantation, fecal pellets were col-
lected and immediately frozen at 280°C. Approximately 25mg of fecal pellets of two control mice and
two ampicillin-exposed mice each were homogenized into 500 ml of beef broth medium (10.0 g of beef
extract, 10.0 g of peptone, and 5.0 g of NaCl in 1.0 liter of water, pH 7.2) to produce fecal suspensions.
The donor fecal samples were not pooled, and a fecal suspension was prepared for each donor mouse.
Fifty microliters of each fecal suspension was administered by gavage to six recipient germfree mice,
and the mice were maintained for 4 weeks before sacrifice (total n= 24 mice). For cohousing experi-
ments, antibiotic-pretreated and -naive female mice were pooled at weaning and maintained together
for 4 weeks until the study endpoint.
C. rodentium infection. The nalidixic acid (NAL)-resistant Citrobacter rodentium strain ICC169 was
grown overnight at 37°C in Luria broth (LB) supplemented with NAL (50mg/ml; Sigma). Mice were
infected with a single oral dose of 1 108 bacteria at 7 weeks of age and maintained for 14 days. To
assess C. rodentium colonization, cecal, colonic, and mesenteric lymph node (MLN) tissues were homog-
enized in phosphate-buffered saline (PBS), diluted, and inoculated onto LB plates supplemented with
NAL (LB-NAL). Colonies were counted after 18 h of aerobic culture at 37°C.
Ovalbumin-induced food allergy. For ovalbumin (OVA)-induced food allergy, C57BL/6 mice were
sensitized twice intraperitoneally (i.p.) with 50mg of OVA (Sigma; A5503-5G) emulsified in aluminum hy-
droxide (Imject alum, 77161; Thermo Scientific) on days 0 and 14, followed by challenge via oral gavage
on days 28, 29, 30, and 31 with 60mg of OVA. Signs were scored for 40min after each challenge, with
scores indicating the following: 0, no sign of reaction; 1, repetitive scratching and rubbing around the
nose/mouth and head and ear canal digging with hind legs; 2, decreased activity with an increased re-
spiratory rate, pilar erecti, and/or puffing around the eyes and/or mouth; 3, labored respiration and cya-
nosis around the mouth and tail and/or periods of motionless for more than 1min or lying prone on
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stomach; 4, slight or no activity after prodding/whisker stimuli or tremors and convulsion; and 5, death.
Cumulative scores over 4 days were calculated by adding all four individual scores per mouse. Mice
were sacrificed by CO2 inhalation after the last challenge, and blood and tissue samples were collected.
For splenic antigen-specific Th2 cytokine ELISAs, spleens were pushed through a 40-mm cell strainer and
washed with PBS prior to red blood cell lysis. Splenocytes were seeded into 96-well plates in RPMI 1640
medium (Gibco 21875-034 plus fetal calf serum [FCS] and penicillin-streptomycin) supplemented with
200mg/ml of OVA protein. After 4 days in culture, supernatants were collected and cytokines were quan-
tified by IL-5 (88-7054-88) and IL-13 (88-7137-88) ELISA, according to the manufacturer’s instructions
(eBioscience).
Leukocyte isolation. For lamina propria (LP) leukocyte isolation, gastrointestinal tissues were
opened longitudinally, washed, and cut into sections that were incubated for 1 h in Hanks’ balanced salt
solution with 10% FCS and 5mM EDTA at 37°C to remove epithelial cells. The remaining tissue was
digested at 37°C for 50min in a shaking incubator with 15mM HEPES, 500 U/ml of type IV collagenase
(Sigma-Aldrich), and 0.05mgml21 of DNase I in supplemented RPMI 1640 medium. Cells were then lay-
ered onto a 40/80% Percoll gradient and centrifuged, and the interface was washed in PBS with 0.5% bo-
vine serum albumin (BSA). Lymph node cell suspensions were prepared by digestion in 500 U/ml of type
IV collagenase in RPMI 1640 for 15min followed by passage through a cell strainer using a syringe
plunger. Lung cell suspensions were prepared by perfusing the lung with PBS followed by passage
through a cell strainer.
Flow cytometry, T-cell restimulation, and cell counting. Cells were stained with a fixable viability
dye and a combination of the following antibodies: anti-mouse CD45 (clone 30-F11), CD11c (N418),
major histocompatibility complex class II (MHC-II; M5/114.15.2), F4/80 (BM8), CD103 (M2E7), CD11b (M1/
70), CD3e (145-2C11), CD4 (RM4-5), CD8 (53-6.7), T-cell receptor b (TCRb ; H57-597), neuropilin-1 (3E12),
or an IgG isotype control (all from BioLegend). Fc block (anti-CD16/CD32; Affymetrix) was included to
minimize nonspecific antibody binding. For intracellular cytokine staining, cells were incubated at 37°C
for 3.5 h in complete Iscove's Modified Dulbecco's Medium (IMDM) supplemented with 0.1mM phorbol
12-myristate 13-acetate, 1mM ionomycin, 1:1,000 brefeldin A (eBioscience), and GolgiStop solutions (BD
Biosciences) at 37°C in a humidified incubator with 5% CO2. Following surface staining, cells were fixed
and permeabilized with the Cytofix/Cytoperm fixation/permeabilization solution kit (CC-kit; BD
Biosciences) according to the manufacturer’s instructions. Cells were stained for 50min with antibodies
to IL-17A (TC11-18H10.1), gamma interferon (IFN-g; XMG1.2), and tumor necrosis factor alpha (TNF-a;
MP6-XT22). For intranuclear staining of transcription factors, cells were fixed and permeabilized with the
Foxp3/transcription factor staining buffer set (eBioscience) after surface staining according to the manu-
facturer’s instructions. Cells were stained for 50min with antibodies to FoxP3 (FJK-16s) and RORgt (B2D)
from Invitrogen. Samples were acquired on an LSRII Fortessa (BD Biosciences) and analyzed using
FlowJo software.
Dendritic cell/T-cell cocultures. For DC/T-cell cocultures, CD11c1 DCs were isolated by positive
selection from MLN single-cell suspensions using CD11c ultrapure mouse microbeads (Miltenyi Biotech).
Naive CD41 T cells were isolated by negative selection from splenic single-cell suspensions using the
MagCellect mouse naive CD41 T-cell isolation kit (R&D Systems). DCs and T cells were cocultured at 1:5
ratios (20,000 DCs and 100,000 T cells) in a round-bottom 96-well plate for 72 h in the presence of anti-
CD3 agonistic antibody (BD Bioscience) at a 1-mg/ml final concentration with 5 ng/ml of TGF-b1 and
10 ng/ml of IL-2 (both from R&D Systems). Foxp31 Tregs were stained as described above, and samples
were acquired on an LSRII Fortessa (BD Biosciences) and analyzed using FlowJo software.
16S rRNA analyses. Intestinal contents and fecal pellets were collected from mice and frozen in liq-
uid nitrogen when collected and stored at –80°C. DNA extraction was completed using a DNeasy
PowerSoil HTP 96 kit (Qiagen) according to the manufacturer’s protocol. The V4 region of the 16S rRNA
was amplified using the 515F/806R primer pair with barcodes located in the forward primer as described
previously (79). PCRs were completed in triplicate for each sample, and amplicon DNA concentrations
were quantified using a PicoGreen assay (Invitrogen). Amplicons were pooled at equal quantities of DNA,
and PCR cleanup was done using a QIAquick PCR purification kit (Qiagen). DNA was quantified using the
QuBit double-stranded DNA (dsDNA) high-sensitivity assay (Invitrogen), and the amplicon library was pooled
at equimolar concentrations. The 16S rRNA library was sequenced on an Illumina MiSeq 2 150-bp platform
at New York University Langone Genome Technology Center. Sequence reads were processed using the
QIIME2 pipeline (80); reads were filtered and trimmed and an ASV table generated using the DADA2 pipeline
(81). Taxonomy was assigned using SILVA 138 (released December 2019). Alpha (Shannon and observed
ASVs) and beta diversity (unweighted and weighted UniFrac) analyses, rarefied at 5,000 reads, were per-
formed using the QIIME2 pipeline, and plots were generated in R using ggPlot2. Taxonomic abundance plots
were generated using the Phyloseq package, and differential abundance plots and heat maps were gener-
ated using the DeSeq2 and Complex Heatmap packages in R (82, 83).
Statistical analysis. Statistical analysis was performed with Prism 6.0 (GraphPad Software). The non-
parametric Mann-Whitney U test was used for all direct statistical comparisons between two groups.
Multiple-group comparisons were performed by one-way analysis of variance (ANOVA) followed by
Holm-Sidak’s multiple-comparisons correction. Differences were considered statistically significant when
the P value was ,0.05. In figures, P values are indicated as follows: *, P, 0.05; **, P, 0.01; ***, P, 0.001;
and ****, P, 0.0001. Differentially abundant ASVs were determined by contrasting the relevant treat-
ment groups and selecting for ASVs that were significant using a Benjamini-Hochberg false-discovery
rate (FDR; P value) of ,0.01.
Ethics statement. All animal experimentation at the University of Zurich was reviewed and
approved by the Zurich Cantonal Veterinary Office (licenses ZH140/2017 and ZH086/2020 to A.M.) and
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adhered to the rules and regulations of the Swiss National Veterinary Office. All mouse experiments at
NYU Langone were approved by the New York University Langone Institutional Animal Care and Use
Committee (IACUC protocol IA16-00785) and complied with federal and institutional regulations.
Data availability. The 16S sequencing data are available through EBI with accession number
PRJEB42154 or via Qiita with accession code Study 13509.
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